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Knowledge artifacts in digital repositories for clinical decision support (CDS) can promote the use of 
CDS in clinical practice. However, stakeholders will benefit from knowing which they can trust before 
adopting artifacts from knowledge repositories. We discuss our investigation into trust for knowledge 
artifacts and repositories by the Patient-Centered CDS Learning Network’s Trust Framework Working 
Group (TFWG). The TFWG identified 12 actors (e.g. vendors, clinicians, policy makers, etc.) within a 
CDS ecosystem who each may play a meaningful role in prioritizing, authoring, implementing, or 
evaluating CDS; and developed 33 recommendations distributed across nine “trust attributes.” The trust 
attributes and recommendations represent a range of considerations such as the “Competency” of 
knowledge artifact engineers, and the “Organizational Capacity” of institutions that develop and 
implement CDS. The TFWG findings highlight an initial effort to make trust explicit and embedded 
within CDS knowledge artifacts and repositories, and thus more broadly accepted and used.   
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INTRODUCTION 
Clinical decision support (CDS) has been defined as a “process for enhancing health-related decisions” 
(Osheroff et al., 2012) that provides “clinicians, staff, patients, or other individuals with knowledge and 
person-specific information, intelligently filtered or presented at appropriate times, to enhance health and 
health care.”(Osheroff et al., 2007) CDS has become more available via Meaningful Use-certified 
electronic health records (EHRs) and has been identified as a key component for disseminating clinical 
guidelines into clinical practice and achieving continuous improvement within Learning Health Systems. 
(Bates et al., 2003; Middleton, 2009; Middleton, Sittig and Wright, 2016) 
 
Despite its increasing availability, CDS arguably has not achieved its full value potential for impacting 
the costs, quality, or outcomes of care.(Hillestad et al., 2005; Jones et al., 2014) Significant limitations 
still exist for how evidence gets incorporated into routine clinical practice. Limitations include costs for 
developing CDS and non-scalable implementations within and across health systems.(Sittig et al., 2008) 
To address these challenges, policy-makers, developers, and researchers are exploring methods for 
encapsulating the clinical logic embedded in care guidelines into computable objects called “knowledge 
artifacts,”(Peleg, 2013) and then offering those knowledge artifacts via publicly available 
repositories.(Hongsermeier et al., 2011; Ozawa and Sripad, 2013; Greenes, 2017) A knowledge artifact 
represents evidence in machine readable code that invokes various actions via EHRs or other applications 
in clinical workflows such as patient-specific alerts, or documentation templates and order sets for 
providers. Those actions can be executed based on rules-based logic or increasingly sophisticated 
algorithms. A knowledge artifact repository, like the Agency for Healthcare Research and Quality’s CDS 
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Connect (http://cds.ahrq.gov),(CDS Connect: Contract Year 1 Final Report, 2017) is analogous to an 
“app store” wherein a customer can compare and contrast different tools to be used on a smartphone.  
 
Thus, a repository makes CDS knowledge artifacts available to CDS developers and implementers for 
embedding within CDS tools and services. This approach holds promise for making CDS development 
more efficient and increasing the availability of shareable knowledge artifacts for CDS to care delivery 
organizations and ultimately their providers and patients within a CDS knowledge management lifecycle. 
The Analytic Framework for Action (AFA) illustrates interconnected areas within a lifecycle, which are: 
1) prioritizing clinical evidence to be transformed into an artifact, 2) authoring an artifact in ways that can 
be machine readable within an EHR; 3) implementing an artifact; 4) measuring an artifact’s effects on 
care delivery and patient outcomes; and 5) contextual factors such as governance and legal requirements 
that influence how an artifact is managed and maintained over time (See Figure 1). These areas within the 
AFA ideally contribute to developing Learning Health Systems.(Marcial et al., 2018) 
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Figure 1: The Analytic Framework for Action Depicts a CDS Knowledge Management Lifecycle 
 
The success of CDS Connect and other knowledge artifact repositories will require not only further 
technical sophistication, but also concomitant policies and governance procedures that help end users 
decide that they can trust knowledge artifacts prior to use. For example, if a community hospital wants to 
download a publicly available knowledge artifact for opioid prescribing CDS, how would it know in 
advance that the knowledge artifact is based on reliable evidence, that the artifact’s evidence is routinely 
updated, and that third-parties (e.g. public or private payers, The Joint Commission, etc.) approve of the 
knowledge artifact and its evidence? Our work is premised on experience that trustworthy knowledge 
artifacts, and biomedical knowledge more broadly, will catalyze the development, distribution, 
measurement, and use of CDS for patient-centered care within Learning Health Systems.(Middleton, 
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2009; Hongsermeier et al., 2011) In this paper, we describe the efforts of the Patient-Centered Clinical 
Decision Support Learning Network Trust Framework Working Group to (a) describe the people 
(“actors”) in the CDS ecosystem; and (b) consider their roles with respect to trust (e.g., who needs to trust 
whom, and what they would need to know or demonstrate to ensure trust?). The purpose of this effort was 
to identify actionable recommendations that would promote trustworthiness of knowledge artifacts.  
 
The Patient-Centered Clinical Decision Support Learning Network (Learning Network) is funded by the 
Agency for Healthcare Research and Quality (U18 HS024849) to promote the dissemination of patient-
centered outcomes research into clinical workflows via CDS. The Learning Network chartered a Trust 
Framework Work Group (TFWG) to investigate ways that the CDS marketplace and research 
communities can establish and promote trust in knowledge artifacts and repositories. Toward that end, the 
TFWG had two goals: 1) identify barriers and facilitators to operationalizing a trust framework for one or 
more use cases; and 2) recommend how trust could promote fair, equitable, transparent, and trustworthy 
sharing of knowledge artifacts within a multi-stakeholder CDS ecosystem. We provide the results that 
include attributes for trust, recommendations, and next steps that the field can take to promote trust in 
knowledge artifacts and repositories for CDS. 
 
Trust and Complex Systems 
Trust is a challenging multi-dimensional concept defined as one party’s implicit “willingness to be 
vulnerable to another for a given set of tasks.”(Hall et al., 2001) Trust in health systems is frequently 
evaluated in a number of approaches including: terms of perceived fairness; fidelity to patients’ best 
interests; system trust or confidence in policies and procedures; and confidentiality and privacy.(Hall et 
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al., 2001; Ozawa and Sripad, 2013; Platt, Jacobson and Kardia, 2018) Research examining the role of 
trust in interpersonal relationships frequently considers the honesty, competency, communication, or 
confidence in the reliability of relevant parties.(Ozawa and Sripad, 2013) 
 
Trust is a critical component of complex technical systems(Luhmann and Poggi, 2005) and is broadly 
recognized as a necessary attribute of health IT.(McGraw et al., 2009) Examples include those from a 
2014 National Science Foundation workshop that identified trust as one of four broad system-level 
requirements for a high functioning Learning Health System,(Friedman et al., 2014) and the Office of the 
National Coordinator’s draft Trusted Exchange Framework and Common Agreement (TEFCA).(Everson, 
2018) Yet whereas TEFCA focuses on the trusted exchange of data, we pursued an investigation to make 
recommendations for the trusted exchange of knowledge. 
      
The Trust Framework Work Group (TFWG) 
 
We gathered 15 volunteer members from diverse backgrounds including clinicians, policy makers, and 
CDS vendors (see Acknowledgements) who met bi-weekly between February and August 2018. Members 
participated in moderated discussions, internal surveys, individual exercises, and iterative group editing of 
draft documents. A key exercise included members documenting aspects of trust from their respective 
perspectives that our group then distilled into fundamental attributes of trust (which we labeled as “trust 
attributes”) and recommendations. As this effort was exploratory and to our knowledge lacked a 
theoretical framework to build from, we iteratively vetted our efforts and the results with external 
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stakeholders including participants in the CDS Connect Work Group. A more detailed description of the 
methods is detailed in the TFWG’s white paper that is available online.(Middleton et al., 2018) 
 
DETERMINING CDS ACTORS, TRUST ATTRIBUTES, AND RECOMMENDATIONS FOR 
PROMOTING TRUST 
 
The TFWG identified and agreed on definitions of actors, people within a CDS ecosystem that play one 
or more meaningful roles in prioritizing, authoring, implementing, and evaluating knowledge artifacts. 
The actors included patients, those within care delivery organizations (e.g., clinicians, population health 
end users, etc.), vendors (e.g., health IT vendors, Knowledge Distributors), payers, and more. We list the 
actors alphabetically in Table 1. 
 
Table 1: Definition of actors participating in an ecosystem of knowledge translation and 
specification for implementation as CDS. 
 
Actors Description Examples 
Clinicians Medical professionals who care for patients. Physicians, Nurses 
Health IT 
Vendors 
Commercial entities that provide health-related 
technology solutions. 
EHR vendors, CDS vendors, 
Health app developers 
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Professionals such as domain experts and 
professional societies who write guidelines or other 
materials that provide clinical evidence to users in 
unstructured format (narrative text, image files, 
etc.).* 
United States Preventive 
Services Task Force, American 
College of Physicians  
Knowledge 
Curators 
Professionals who maintain knowledge artifact 
libraries and help ensure evidence is trustworthy 





Professional organizations that package, market, or 
sell knowledge artifacts as private organizations or 
in public-private partnerships. 
CDS Connect, First Databank 
Knowledge 
Engineers 
Professionals who translate clinical guidelines into 
artifacts in semi-structured human readable form 
(L2)*, a computer interpretable form (L3)*, and/or 
machine-executable formats (L4).* 
Medical informaticists, 




A governance body that reviews and approves CDS 
to be used in an organization or across networks. 
Hospital CDS committees, 
Integrated health network 
knowledge management 
committees 
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Patients Persons who are the ultimate decision-makers in 
their healthcare and managing their health. 
Adults, Guardians 
Payers Organizations that pay clinicians or patients for 
health-related activities. 
Blue Cross Blue Shield, United 
Healthcare 
Policymakers Persons who develop legal, regulatory, or policy 
guidance that guide care or payment. 
Centers for Medicare and 






Professionals who support clinicians, clinical 
teams, and patients by monitoring population 
health trends and recommending actions. 
Care Managers, Care 





Professionals who measure the impact of 
implemented CDS within health IT. 
Researchers, Organization-
specific quality improvement 
specialists  
*L1-L4 are Boxwala et al.’s four levels of knowledge abstraction interpretability from human readable (L1) to 
machine executable (L4).(Boxwala et al., 2011) 
 
Taking into consideration the actors in the CDS ecosystem, their roles, and their responsibilities to one 
another, we developed and defined nine trust attributes, which provide different levels of consideration. 
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For example, the “Competency” trust attribute represents the needs and expectations of an individual 
actor (e.g. knowledge engineer) whereas “Organizational Capacity” represents organization-level needs 
and expectations. Based on the nine trust attributes, the TFWG articulated 33 recommendations for action 
to ensure the attributes were reflected across the ecosystem (see Table 2).  
 





Competency An actor who authors a 
knowledge artifact is deemed to 
be competent in the role played 
in the CDS ecosystem. For 
example, an author of a 
knowledge artifact should be 
judged competent, qualified, 
and an appropriate authority to 
develop the artifact based on 
factors such as past 
performance, professional 
qualifications, or certifications. 
1.1 Authors have descriptions with 
background information including affiliations, 
years participating, and frequency of 
participation. 
1.2 Authors promote respect and dignity 
when providing feedback. 
1.3 Authors are credentialed by an agreed-
upon entity through education or training, 
experience, and dependability. 
1.4 Knowledge professionals are certified that 
they are competent in the knowledge 
management lifecycle;(Wright et al., 2009, 
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pp. 334–346; Glaser and Hongsermeier, 2014) 
can competently interpret, encode, and 
execute knowledge; and are competent in 
addressing issues of conflict of interest. 
1.5 Competency should apply to both 
individuals and organizations.  
Compliance A knowledge artifact should 
conform to defined standards 
and criteria including copyright 
and intellectual property. 
2.1 Knowledge artifacts provide human-
readable and machine-readable forms 
(whenever applicable) as well as supporting 
references. 
2.2 Knowledge artifacts are implemented in 
compliance with best practices for safe and 
effective implementation. 
2.3 Knowledge artifacts are encoded using 
current standards for controlled medical 
terminologies, value sets, clinical data 
models, and knowledge representation 
formalisms. 
Consistency A knowledge artifact should 
repeatedly generate expected 
results over time when given 
3.1 Authors take on responsibility of ensuring 
accurate knowledge translation and 
specification of a knowledge artifact. 
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requisite inputs (e.g., patient 





The evidence behind an 
executable knowledge artifact is 
documented (discoverable) 
from metadata associated with 
the artifact. Artifacts and their 
contents have clear and 
appropriate reasoning for 
recommendations available to 
the end users. Artifacts are 
accessible to potential users, 
including patients and 
policymakers. 
4.1 Knowledge is made accessible through 
search technology in conjunction with 
effective and helpful key terms. 
4.2 Knowledge can be reliably searched for 
and found over time, so that users can find the 
same knowledge across successive versions. 
4.3 References to supporting evidence are 
clearly labeled and linked (preferably deep 
linked) to relevant supporting information. 




The evidence instantiated 
within an artifact must apply to 
the clinical condition it is meant 
to support. Limitations are 
stated clearly, and the evidence 
supporting the clinical 
5.1 Metadata indicate the date that evidence 
was originally published and the date that 
evidence was last reviewed. 
5.2 Metadata state any known limitations, 
restrictions, or exclusions to any given 
evidence. 
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guideline/predictive model, etc. 
in an artifact is substantiated 
and has clear clinical 
appropriateness. 
5.3 Artifacts contain references to the 
evidence base on which they are built, 
including both narrative guidelines and the 
data supporting those guidelines. 
5.4 Artifacts include metadata for all 
supporting citations. 
5.5 Artifacts include evidence about their 
methods (e.g., order set v. alert), usage 
history, and available outcomes. 
Feedback and 
Updating 
Stakeholders have the 
functional ability to provide 
timely feedback and suggest 
improvements to a knowledge 
artifact. Feedback may be 
directed to diverse actors in the 
ecosystem (knowledge 
engineers, knowledge authors, 
etc.). 
6.1 Systems capture error logs and feedback 
about an artifact within the context of its use 
(e.g., EHR system, clinical setting, crash data 
etc.). 
6.2 Systems provide feedback mechanisms 
including means for users to ask questions 
about an artifact’s context of use. 
6.3 Metadata capture the dates an artifact was 
first and last published, with update dates in 
between. 
6.4 Artifacts contain auditable records of 
updates and changes over time. 
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6.5 Artifacts are updated based in part on 
feedback from their operational performance 
over time. 
6.6 Authors provide bidirectional feedback to 




An organization that sponsors 
knowledge artifact development 
or implementation (or both) 
should have the necessary 
funding, staffing, and resources 
to maintain a knowledge artifact 
and measure its effect(s). 
7.1 Develop skills and capacity of staff, 
systems, and resources that support 
implementation, ongoing evaluation, 
feedback, communications, and governance. 
Include implementation guidance with 
artifacts that conveys the necessary resources 
to implement that artifact. 
7.2 Knowledge artifacts include 
implementation guidance that conveys the 
necessary resources to implement that artifact. 
Patient- 
centeredness 
When possible, a knowledge 
artifact should leverage patient-
centered outcome research 
findings and/or patient-specific 
information (the patient’s 
8.1 Requirements for patient-level or patient-
generated data input are clearly indicated. 
8.2 Evidence that accounts for patient-level or 
patient-generated data is clearly indicated. 
8.3 Consent for use of patient-level or patient-
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clinical data, patient 
preferences, patient-generated 
health data, patient-reported 
outcomes) to support decisions 
by individual patients, their 
approved caregivers, and/or 
their care teams. 
generated data is clearly indicated. 
Transparency A knowledge artifact should be 
applied and used ethically to 
clearly convey all potential 
conflicts of interest and 
disclosures of interest related to 
its development or 
recommendation to detect bias 
or discrimination in its use. 
9.1 Clearly indicated policies describe the 
procedures for implementing, updating, 
revising, and removing artifacts. 
9.2 Clearly indicated policies address conflict 
of interest. 
9.3 Knowledge artifacts are consistently 
implemented with licensing agreements and 
any secondary use rights are explicit. 
9.4 Knowledge artifacts are consistently 
implemented in ways that support equity in 
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The TFWG examined the issue of defining, building, and maintaining trust among actors who develop, 
exchange, implement, or use knowledge artifacts for CDS. We identified 12 relevant actors (see Table 1) 
and developed nine trust attributes with 33 associated recommendations (see Table 2). These findings 
represent to our knowledge the first time the elements of trust for knowledge artifacts within a CDS 
ecosystem have been comprehensively defined. We address the trust attributes within four knowledge 
management lifecycle domains below as depicted within the AFA (see Figure 1); prioritizing, authoring, 
implementing, and measuring impact. Each trust attribute is identified in italics. 
 
 
      
Trust Attributes for Prioritizing Evidence: Evidence-based and Patient-centeredness 
 
Accurate and reliable evidence is essential for trust in any knowledge artifact used in a CDS system. 
Repositories and the artifacts within should integrate a formal Evidence-based rating system such as 
GRADE (GRADE Welcome to the GRADE working group, 2018) so that end users can assess and weigh 
the quality of the evidence within a knowledge artifact for CDS. In addition, the evidence should be 
interpreted and applied in a Patient-centered manner whenever possible given a decision context and 
includes unique patient data and context, patient preferences, patient-reported outcomes, or other patient-
generated data.  
 
Trust Attributes for Authoring: Competency, Consistency, and Discovery and Accessibility 
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Authoring-related trust attributes include considerations around the Competency (qualifications and past 
performance) of artifact authors, as well how well and reliably they implement knowledge artifacts that 
lead to consistency in the use of CDS. Competency could be assessed by the community, or by a 
governing body such as a professional society certification, vendor certifications, or licensure boards as 
well as by authors’ experience and previous track records. Consistency relates to the reliable and 
consistent performance of an implemented knowledge artifact as CDS across disparate implementations 
of health IT as well as across different care delivery systems or settings of care. CDS Hooks represents 
one emerging standard and solution for consistently and reliably triggering the logic within knowledge 
artifacts. Discoverability and Accessibility extends to the evidence trail and/or the provenance of a 
knowledge artifact and should be traceable to the sources such as clinical guidelines. 
 
Trust Attributes for Implementation: Organizational capacity, Compliance, and Transparency 
 
This is essential to be both Compliant with the current best practices for knowledge representation 
standards and achieving “the 5 rights” for CDS implementation.(Osheroff et al., 2012) Implementing 
organizations (e.g. care delivery organizations, IT vendors, knowledge vendors, etc.) must have the 
Organizational Capacity to safely and effectively implement CDS, monitor its use, and keep the 
implemented CDS up to date. This suggests that an organization’s EHR and data readiness for 
implementing knowledge artifacts are directly linked to the quality of expected outcomes produced by the 
artifact, and its trustworthiness in practice. Maturity models for EHR and health IT infrastructures may be 
useful in assessing initial capacity for knowledge artifact implementations but could also be further 
developed and extended to consider Organizational Capacity for adopting use of knowledge artifacts. For 
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example, the United States Food and Drug Administration is considering an organization-level approach 
as part of its Software as a Medical Device (SaMD) pre-certification process.(Digital Health Software 
Precertification (Pre-Cert) Program, 2018). Finally, full Transparency must exist in the implementation 
to capture any assumptions made, deviations from guideline evidence logic, or other changes in data 
structures used in CDS. We refer readers to the work of the Center for Open Science’s Transparency and 
Openness Promotion guidelines for considerations in this area.(Nosek et al., 2015; TOP Guidelines, 2018) 
 
Trust Attribute for Measurement: Feedback and Updating 
 
Key to Learning Health Systems is the capacity to provide Feedback and Updates on the implemented 
knowledge artifact or CDS from the vantage point of any user: whether that be a physician, nurse, or other 
member of the care team, as well as the patient him or herself.(Bates et al., 2003) Feedback and Updates 
may include an end-user’s subjective assessment, as well as more quantitative assessments of impact. 
These may include the methods for measuring CDS impact on near- and long-term process-level and 
patient-level outcomes. Feedback ought to occur at multiple levels: from a user to the system 
implementers, to the CDS author, IT system designers, and potentially even to the creators of the primary 
evidence. 
 
The areas we outlined above have significant implications for promoting trust in the ways clinical 
knowledge is built and maintained such as noting common metadata schema across public and private 
knowledge repositories, a direct linkage to primary source documentation, and any ability to determine 
that the evidence applies in an appropriate manner to the patient context at hand. 
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CDS Connect is applying the trust attributes and recommendations for promoting trust to the development 
of its platform and metadata schema. Future efforts should focus on linking trust attributes to policy, 
governance, and translation into practice. For example, we foresee further explication of the Competency 
trust attribute and providing recommendations as to how Competency can be economically 
operationalized to help prospective end users inspect and compare offerings. Policies for ensuring the 
validity of CDS encoded in knowledge artifacts or standardized labeling for knowledge artifacts would 
help systems such as CDS Connect become scalable enterprises but require further research to ensure 
policies and standards are evidence-based. 
      
Gaps identified in the development of the trust framework also point to areas where future capabilities 
might be developed. We are excited about the prospect of reporting systems that enable the Feedback and 
Updating trust attribute such as the automatic submission of CDS and EHR performance data for 
knowledge artifacts. We believe that attribute would also be of great value to key actors (authors, 
implementers, policy makers) and would be a major step toward supporting compliance in Learning 
Health Systems. We also believe that an important area of future work will be designing for Patient-
Centeredness in repositories, such as providing robust means for patients themselves to compare and 
contrast artifacts for personal use or use of metadata that inform potential users in the ways that evidence 
is patient-centered. In parallel, we believe additional work to promote Transparency in patented 
knowledge will better guide stakeholders how to develop and implement knowledge artifacts (or not).  
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We anticipate future work in trust for CDS knowledge artifacts will refine the trust attributes themselves, 
and the recommendations, based on real-world experience. An area for further investigation would be 
whether and how levels of trust vary by actors; for example, the degrees to which providers versus 
patients trust—or perceive the need to trust—CDS knowledge artifacts. We expect further work will also 
explore potential trust attributes related to knowledge artifact security (e.g. intellectual property and 
provenance), the issues of which differ from data security that TEFCA addresses. We furthermore hope to 
develop methods (assessment instruments or rating scales) that may be based upon the attributes to 
develop one or more trust metrics for knowledge artifacts. In this area, we are tracking the exciting 
developments coming out of the HL7 CDS Work Group that include EHR standards for interoperable 
clinical guidelines—CPGonFHIR (Representation of Clinical Practice Guideline Recommendations in 
FHIR, 2019)—and interoperable systematic reviews--EBMonFHIR (EBMonFHIR - Clinical Decision 
Support - Confluence, 2019). Each of these efforts seeks to enable streamlined exchanges of knowledge 
through standardized and computable artifacts for CDS, and if successful, could scale clinical knowledge 
exchange beyond current capabilities. However, more efficient exchange is unlikely to promote use (and 
reuse) of that knowledge unless care delivery organizations, providers, and patients can trust artifacts’ 
accuracy and timeliness. We are contributing to these efforts to inform stakeholders how trust plays a 
foundational role critical to collective success, and we are thankful for the input and openness of CDS 
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Shareable and computable knowledge artifacts for CDS has long been a goal within informatics given the 
potential to more effectively integrate biomedical knowledge into EHRs and Learning Health Systems. 
Trust in knowledge artifacts will be a key feature of promoting and sustaining a knowledge-sharing 
ecosystem comprised of multiple stakeholders and information systems. We identified actors in a CDS 
ecosystem, trust attributes, and recommendations that can enhance knowledge artifacts that support 
efforts for their adoption and implementation. We advocate for further efforts in this area to advance the 
trustability of biomedical knowledge and promote its implementability and scalability to make CDS 
effective in Learning Health Systems.   
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